{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:01:33Z","timestamp":1761973293601,"version":"build-2065373602"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,4,16]],"date-time":"2020-04-16T00:00:00Z","timestamp":1586995200000},"content-version":"vor","delay-in-days":106,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011103","name":"Sixth Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011103","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013327","name":"H. Lundbeck A\/S","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013327","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011110","name":"UCB","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011110","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015756","name":"Cilag","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015756","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019944","name":"Sanofi-Aventis Deutschland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019944","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004321","name":"Shire","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008897","name":"Janssen Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011725","name":"Servier","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["01GV0611","01GV0615"],"award-info":[{"award-number":["01GV0611","01GV0615"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002957","name":"Technische Universit\u00e4t Dresden","doi-asserted-by":"publisher","award":["EK 164082006"],"award-info":[{"award-number":["EK 164082006"]}],"id":[{"id":"10.13039\/501100002957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001645","name":"Boehringer Ingelheim Fonds","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001645","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["NeuroImage: Clinical"],"published-print":{"date-parts":[[2020]]},"DOI":"10.1016\/j.nicl.2020.102268","type":"journal-article","created":{"date-parts":[[2020,4,23]],"date-time":"2020-04-23T20:53:05Z","timestamp":1587675185000},"page":"102268","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Neural correlates of NOS1 ex1f-VNTR allelic variation in panic disorder and agoraphobia during fear conditioning and extinction in fMRI"],"prefix":"10.1016","volume":"27","author":[{"given":"Isabelle C.","family":"Ridderbusch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunbo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heike","family":"Weber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Reif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine","family":"Herterich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Str\u00f6hle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1238-6225","authenticated-orcid":false,"given":"Bettina","family":"Pfleiderer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2445-9778","authenticated-orcid":false,"given":"Volker","family":"Arolt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans-Ulrich","family":"Wittchen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrike","family":"Lueken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tilo","family":"Kircher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Straube","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nicl.2020.102268_bib0001","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.euroneuro.2011.08.008","article-title":"Cost of disorders of the brain in Europe 2010","volume":"21","author":"Gustavsson","year":"2011","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.nicl.2020.102268_bib0002","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.euroneuro.2011.07.018","article-title":"The size and burden of mental disorders and other disorders of the brain in Europe 2010","volume":"21","author":"Wittchen","year":"2011","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.nicl.2020.102268_bib0003","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1146\/annurev.neuro.27.070203.144212","article-title":"Genetic approaches to the study of anxiety","volume":"27","author":"Gordon","year":"2004","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.nicl.2020.102268_bib0004","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1146\/annurev.psych.57.102904.190118","article-title":"Genetics of affective and anxiety disorders","volume":"57","author":"Leonardo","year":"2006","journal-title":"Annu. Rev. Psychol."},{"key":"10.1016\/j.nicl.2020.102268_bib0005","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/pcn.12291","article-title":"Genetics of anxiety disorders. Genetic epidemiological and molecular studies in humans","volume":"69","author":"Shimada-Sugimoto","year":"2015","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.nicl.2020.102268_bib0006","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1176\/appi.ajp.2010.09091379","article-title":"Research domain criteria (RDoC) toward a new classification framework for research on mental disorders","volume":"167","author":"Insel","year":"2010","journal-title":"Am. J. Psych."},{"key":"10.1016\/j.nicl.2020.102268_bib0007","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/psyp.12518","article-title":"The NIMH research domain criteria initiative background, issues, and pragmatics","volume":"53","author":"Kozak","year":"2016","journal-title":"Psychophysiology"},{"key":"10.1016\/j.nicl.2020.102268_bib0008","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/mp.2015.88","article-title":"Neural signatures of human fear conditioning. An updated and extended meta-analysis of fMRI studies","volume":"21","author":"Fullana","year":"2016","journal-title":"Mol. Psych."},{"key":"10.1016\/j.nicl.2020.102268_bib0009","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.neubiorev.2017.02.026","article-title":"Don't fear 'fear conditioning'. Methodological considerations for the design and analysis of studies on human fear acquisition, extinction, and return of fear","volume":"77","author":"Lonsdorf","year":"2017","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.nicl.2020.102268_bib0010","doi-asserted-by":"crossref","first-page":"e5865","DOI":"10.1371\/journal.pone.0005865","article-title":"Human fear conditioning and extinction in neuroimaging. A systematic review","volume":"4","author":"Sehlmeyer","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.nicl.2020.102268_bib0011","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.neuroimage.2017.06.054","article-title":"Active avoidance and attentive freezing in the face of approaching threat","volume":"158","author":"Wendt","year":"2017","journal-title":"Neuroimage"},{"key":"10.1016\/j.nicl.2020.102268_bib0012","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.euroneuro.2018.11.1108","article-title":"Characterizing the nature of emotional-associative learning deficits in panic disorder. An fMRI study on fear conditioning, extinction training and recall","volume":"29","author":"Schwarzmeier","year":"2019","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.nicl.2020.102268_bib0013","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1586\/ern.09.161","article-title":"Current findings of fMRI in panic disorder. Contributions for the fear neurocircuitry and CBT effects","volume":"10","author":"Carvalho","year":"2010","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.nicl.2020.102268_bib0014","doi-asserted-by":"crossref","first-page":"429","DOI":"10.3758\/BF03210947","article-title":"Neural organization of the defensive behavior system responsible for fear","volume":"1","author":"Fanselow","year":"1994","journal-title":"Psychon. Bull. Rev."},{"key":"10.1016\/j.nicl.2020.102268_bib0015","doi-asserted-by":"crossref","first-page":"12236","DOI":"10.1523\/JNEUROSCI.2378-09.2009","article-title":"From threat to fear. The neural organization of defensive fear systems in humans","volume":"29","author":"Mobbs","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nicl.2020.102268_bib0016","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S0006-8993(99)01444-4","article-title":"Characterization and regional distribution of nitric oxide synthase in the human brain during normal ageing","volume":"834","author":"Blum-Degen","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/j.nicl.2020.102268_bib0017","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/gbb.12193","article-title":"Neuronal nitric oxide synthase (NOS1) and its adaptor, NOS1AP, as a genetic risk factors for psychiatric disorders","volume":"14","author":"Freudenberg","year":"2015","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.nicl.2020.102268_bib0018","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.neubiorev.2005.02.002","article-title":"Pleiotropic contributions of nitric oxide to aggressive behavior","volume":"30","author":"Nelson","year":"2006","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.nicl.2020.102268_bib0019","article-title":"Nitric oxide interacts with monoamine oxidase to modulate aggression and anxiety-like behaviour","author":"Carre\u00f1o Guti\u00e9rrez","year":"2017","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.nicl.2020.102268_bib0020","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/978-3-211-73574-9_10","article-title":"Behavioural and expressional phenotyping of nitric oxide synthase-I knockdown animals","author":"Wultsch","year":"2007","journal-title":"J. Neural. Transm. Suppl."},{"key":"10.1016\/j.nicl.2020.102268_bib0021","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1126\/science.1720572","article-title":"A requirement for the intercellular messenger nitric oxide in long-term potentiation","volume":"254","author":"Schuman","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.nicl.2020.102268_bib0022","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1101\/lm.1329209","article-title":"Impairments in fear conditioning in mice lacking the nNOS gene","volume":"16","author":"Kelley","year":"2009","journal-title":"Learn. Mem."},{"key":"10.1016\/j.nicl.2020.102268_bib0023","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00213-010-1817-8","article-title":"Pharmacological modulators of nitric oxide signaling and contextual fear conditioning in mice","volume":"210","author":"Kelley","year":"2010","journal-title":"Psychopharmacol. (Berl .)"},{"key":"10.1016\/j.nicl.2020.102268_bib0024","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/hipo.22679","article-title":"The hippocampus integrates context and shock into a configural memory in contextual fear conditioning","volume":"27","author":"Chang","year":"2017","journal-title":"Hippocampus"},{"key":"10.1016\/j.nicl.2020.102268_bib0025","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/j.1460-9568.2009.06624.x","article-title":"Context conditioning and extinction in humans. Differential contribution of the hippocampus, amygdala and prefrontal cortex","volume":"29","author":"Lang","year":"2009","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nicl.2020.102268_bib0026","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/hbm.21224","article-title":"Hippocampal but not amygdalar volume affects contextual fear conditioning in humans","volume":"33","author":"Pohlack","year":"2012","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.nicl.2020.102268_bib0027","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ygeno.2005.11.013","article-title":"Transcription of human neuronal nitric oxide synthase mRNAs derived from different first exons is partly controlled by exon 1-specific promoter sequences","volume":"87","author":"Bros","year":"2006","journal-title":"Genomics"},{"key":"10.1016\/j.nicl.2020.102268_bib0028","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/sj.mp.4001779","article-title":"A neuronal nitric oxide synthase (NOS-I) haplotype associated with schizophrenia modifies prefrontal cortex function","volume":"11","author":"Reif","year":"2006","journal-title":"Mol. Psych."},{"key":"10.1016\/j.nicl.2020.102268_bib0029","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1006\/niox.1998.0189","article-title":"Neuronal-type NO synthase transcript diversity and expressional regulation","volume":"2","author":"Boissel","year":"1998","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.nicl.2020.102268_bib0030","doi-asserted-by":"crossref","first-page":"33082","DOI":"10.1016\/S0021-9258(20)30099-5","article-title":"Structural organization of the human neuronal nitric oxide synthase gene (NOS1)","volume":"269","author":"Hall","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nicl.2020.102268_bib0031","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1615\/CritRevNeurobiol.v13.i1.20","article-title":"Neuronal NOS. Gene structure, mRNA diversity, and functional relevance","volume":"13","author":"Wang","year":"1999","journal-title":"Crit. Rev. Neurobiol."},{"key":"10.1016\/j.nicl.2020.102268_bib0032","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00213-010-1915-7","article-title":"A functional NOS1 promoter polymorphism interacts with adverse environment on functional and dysfunctional impulsivity","volume":"214","author":"Reif","year":"2011","journal-title":"Psychopharmacol. (Berl )"},{"key":"10.1016\/j.nicl.2020.102268_bib0033","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1001\/archgenpsychiatry.2008.510","article-title":"Influence of functional variant of neuronal nitric oxide synthase on impulsive behaviors in humans","volume":"66","author":"Reif","year":"2009","journal-title":"Arch. Gen. Psych."},{"key":"10.1016\/j.nicl.2020.102268_bib0034","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/j.neuroimage.2011.05.034","article-title":"NOS1 ex1f-VNTR polymorphism influences prefrontal brain oxygenation during a working memory task","volume":"57","author":"Kopf","year":"2011","journal-title":"Neuroimage"},{"key":"10.1016\/j.nicl.2020.102268_bib0035","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1002\/jnr.22045","article-title":"The effect of a promoter polymorphism on the transcription of nitric oxide synthase 1 and its relevance to Parkinson's disease","volume":"87","author":"Rife","year":"2009","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.nicl.2020.102268_bib0036","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1017\/S0954579412000661","article-title":"Association of a functional variant of the nitric oxide synthase 1 gene with personality, anxiety, and depressiveness","volume":"24","author":"Kurrikoff","year":"2012","journal-title":"Dev. Psychopathol."},{"key":"10.1016\/j.nicl.2020.102268_bib0037","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.gene.2017.04.048","article-title":"Nitric oxide pathway genes (NOS1AP and NOS1) are involved in PTSD severity, depression, anxiety, stress and resilience","volume":"625","author":"Bruenig","year":"2017","journal-title":"Gene"},{"key":"10.1016\/j.nicl.2020.102268_bib0038","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/scan\/nsv151","article-title":"Converging evidence for an impact of a functional NOS gene variation on anxiety-related processes","volume":"11","author":"Kuhn","year":"2016","journal-title":"Soc. Cogn. Affect. Neurosci."},{"key":"10.1016\/j.nicl.2020.102268_bib0039","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/sj.mp.4001939","article-title":"Mechanisms of fear extinction","volume":"12","author":"Myers","year":"2007","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.nicl.2020.102268_bib0040","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1146\/annurev.psych.121208.131631","article-title":"Fear extinction as a model for translational neuroscience ten years of progress","volume":"63","author":"Milad","year":"2012","journal-title":"Annu. Rev. Psychol."},{"key":"10.1016\/j.nicl.2020.102268_bib0041","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1146\/annurev-clinpsy-050212-185542","article-title":"Fear extinction and relapse state of the art","volume":"9","author":"Vervliet","year":"2013","journal-title":"Annu. Rev. Clin. Psychol."},{"key":"10.1016\/j.nicl.2020.102268_bib0042","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1037\/a0023584","article-title":"Psychological treatment for panic disorder with agoraphobia: a randomized controlled trial to examine the role of therapist-guided exposure in situ in CBT","volume":"79","author":"Gloster","year":"2011","journal-title":"J. Consult Clin. Psychol."},{"key":"10.1016\/j.nicl.2020.102268_bib0043","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00406-009-0065-6","article-title":"Mechanism of action in CBT (MAC): methods of a multi-center randomized controlled trial in 369 patients with panic disorder and agoraphobia","volume":"259","author":"Gloster","year":"2009","journal-title":"Eur. Arch. Psych. Clin. Neurosci."},{"key":"10.1016\/j.nicl.2020.102268_bib0044","doi-asserted-by":"crossref","first-page":"e490","DOI":"10.1038\/tp.2014.130","article-title":"The functional \u22121019C\/G HTR1A polymorphism and mechanisms of fear","volume":"4","author":"Straube","year":"2014","journal-title":"Transl. Psych."},{"year":"2000","series-title":"Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, Text Revision (DSM-IV-TR)","key":"10.1016\/j.nicl.2020.102268_bib0045"},{"year":"1997","series-title":"Composite International Diagnostic Interview According to ICD-10 and DSM-IV","author":"Wittchen","key":"10.1016\/j.nicl.2020.102268_bib0046"},{"key":"10.1016\/j.nicl.2020.102268_bib0047","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.biopsych.2012.07.026","article-title":"Effect of cognitive-behavioral therapy on neural correlates of fear conditioning in panic disorder","volume":"73","author":"Kircher","year":"2013","journal-title":"Biol. Psych."},{"key":"10.1016\/j.nicl.2020.102268_bib0048","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00406-010-0099-9","article-title":"Neural correlates of aversive conditioning: development of a functional imaging paradigm for the investigation of anxiety disorders","volume":"260","author":"Reinhardt","year":"2010","journal-title":"Eur. Arch. Psych. Clin Neurosci."},{"key":"10.1016\/j.nicl.2020.102268_bib0049","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/mp.2012.172","article-title":"MAOA and mechanisms of panic disorder revisited. From bench to molecular psychotherapy","volume":"19","author":"Reif","year":"2014","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.nicl.2020.102268_bib0050","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1159\/000359955","article-title":"Neural correlates of procedural variants in cognitive-behavioral therapy: a randomized, controlled multicenter FMRI study","volume":"83","author":"Straube","year":"2014","journal-title":"Psychother Psych."},{"key":"10.1016\/j.nicl.2020.102268_bib0051","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s00702-014-1311-2","article-title":"Therapygenetics. Anterior cingulate cortex\u2013amygdala coupling is associated with 5-HTTLPR and treatment response in panic disorder with agoraphobia","volume":"122","author":"Lueken","year":"2015","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.nicl.2020.102268_bib0052","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/nrn2317","article-title":"On the relationship between emotion and cognition","volume":"9","author":"Pessoa","year":"2008","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.nicl.2020.102268_bib0053","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nn.4457","article-title":"A cortical-hippocampal-cortical loop of information processing during memory consolidation","volume":"20","author":"Rothschild","year":"2017","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nicl.2020.102268_bib0054","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/npp.2009.109","article-title":"Phasic vs sustained fear in rats and humans role of the extended amygdala in fear vs anxiety","volume":"35","author":"Davis","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.nicl.2020.102268_bib0055","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.janxdis.2010.09.010","article-title":"Differential activity of subgenual cingulate and brainstem in panic disorder and PTSD","volume":"25","author":"Tuescher","year":"2011","journal-title":"J Anxiety Disord"},{"key":"10.1016\/j.nicl.2020.102268_bib0056","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.brat.2008.10.017","article-title":"Impaired discriminative fear-conditioning resulting from elevated fear responding to learned safety cues among individuals with panic disorder","volume":"47","author":"Lissek","year":"2009","journal-title":"Behav. Res. Ther"},{"key":"10.1016\/j.nicl.2020.102268_bib0057","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1176\/appi.ajp.2013.12111484","article-title":"Neural substrates of treatment response to cognitive-behavioral therapy in panic disorder with agoraphobia","volume":"170","author":"Lueken","year":"2013","journal-title":"Am. J. Psych."},{"key":"10.1016\/j.nicl.2020.102268_bib0058","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.cub.2016.01.023","article-title":"Behavioral and neural mechanisms of overgeneralization in anxiety","volume":"26","author":"Laufer","year":"2016","journal-title":"Curr. Biol."},{"key":"10.1016\/j.nicl.2020.102268_bib0059","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1176\/appi.ajp.2009.09030410","article-title":"Overgeneralization of conditioned fear as a pathogenic marker of panic disorder","volume":"167","author":"Lissek","year":"2010","journal-title":"AJP"},{"key":"10.1016\/j.nicl.2020.102268_bib0060","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/da.22353","article-title":"Updated meta-analysis of classical fear conditioning in the anxiety disorders","volume":"32","author":"Duits","year":"2015","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.nicl.2020.102268_bib0061","doi-asserted-by":"crossref","DOI":"10.1002\/mpr.1560","article-title":"Optimizing exposure-based CBT for anxiety disorders via enhanced extinction. Design and methods of a multicentre randomized clinical trial","volume":"26","author":"Heinig","year":"2017","journal-title":"Int. J. Methods Psychiatr. Res."}],"container-title":["NeuroImage: Clinical"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213158220301054?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213158220301054?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T04:32:35Z","timestamp":1761971555000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213158220301054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":61,"alternative-id":["S2213158220301054"],"URL":"https:\/\/doi.org\/10.1016\/j.nicl.2020.102268","relation":{},"ISSN":["2213-1582"],"issn-type":[{"type":"print","value":"2213-1582"}],"subject":[],"published":{"date-parts":[[2020]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neural correlates of NOS1 ex1f-VNTR allelic variation in panic disorder and agoraphobia during fear conditioning and extinction in fMRI","name":"articletitle","label":"Article Title"},{"value":"NeuroImage: Clinical","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nicl.2020.102268","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102268"}}